[Form 4] ADVANCED MICRO DEVICES INC Insider Trading Activity
Rhea-AI Filing Summary
Forrest Eugene Norrod, identified as an officer (EVP & GM DESG) of Advanced Micro Devices, reported a sale of company stock on 09/24/2025. The Form 4 shows he disposed of 2,250 shares of AMD common stock at a price of $165.01 per share, leaving him with 311,598 shares beneficially owned following the transaction. The filing states the shares were sold pursuant to a Rule 10b5-1 trading plan adopted on June 6, 2025.
The Form is signed by Mr. Norrod on 09/25/2025 and lists his address in Santa Clara, CA. No derivative transactions, amendments, or additional compensatory details are provided in this submission.
Positive
- Sale documented under a Rule 10b5-1 plan, indicating pre-established trading intent
- Complete disclosure of transaction details including price ($165.01), date (09/24/2025), and post-transaction holdings (311,598 shares)
- Form signed and dated (09/25/2025), meeting filing formalities
Negative
- Insider disposition of 2,250 shares reduces the reporting person's direct holdings
- No information provided about whether this sale represents a material portion relative to total outstanding company shares
Insights
TL;DR: Officer sold a small portion of holdings under a pre-established 10b5-1 plan; disclosure is routine and compliant.
The sale of 2,250 shares at $165.01 under a Rule 10b5-1 plan is a standard mechanism for insiders to liquidate holdings without implicating contemporaneous material nonpublic information. The residual position of 311,598 shares remains substantial in absolute terms but the filing does not indicate changes to compensation, option exercises, or derivative activity. From a reporting and compliance perspective, the filing is complete and clearly notes the trading-plan adoption date.
TL;DR: Disclosure is transparent and includes required Rule 10b5-1 attribution; no governance red flags in this Form 4.
The Form 4 identifies the reporting person, relationship to the issuer, transaction details, and the 10b5-1 plan adoption date, which aligns with best practices for insider trading transparency. The absence of amendments or derivative activity simplifies the interpretation. The filing does not present any information suggesting timing issues or noncompliance.